[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"somatization\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:somatization":34},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,55,85],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":36,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":54},"100585999","ultra-brief-psychological-treatments-for-emotional-symptoms-and-disorders-100585999",false,"NCT06909669","Ultra-brief Psychological Treatments for Emotional Symptoms and Disorders","Ultra-brief Psychological Treatments for Emocional Symptoms and Disorders: An Efficacy and Efficiency Analysis","UltraPsyBrief","Inclusion Criteria:\n\n\\- Patients presenting negative emotional symptomatology (anxiety, depression or somatizations), mild or moderate. Specifically, they will be included in the study if they present a score ≥ 5 on the PHQ-9, the GAD-7 or the PHQ-15.\n\nExclusion Criteria:\n\n* Bipolar disorder, personality disorder, psychosis or substance abuse, indicated by SCID-5-CV\n* Recent suicide attempt.\n* Severe emotional symptoms (PHQ-15 or GAD-7 ≥ 15; or PHQ-9 ≥ 20).","ALL","18 Years","65 Years",{"count":21,"type":22},184,"ESTIMATED","INTERVENTIONAL",[25],"NA","The main objective of this randomized clinical trial is to study if various modalities of brief (eight sessions) and ultra-brief (four sessions) transdiagnostic cognitive-behavioral treatment work for decrease emotional symptoms and disorders, as well as to find out which variables of cognition and of the intervention process itself are involved in the therapeutic improvement.\n\nThe investigators will compare the interventions of four groups: brief group treatment (1), ultra-brief group treatment (2), ultra-brief individual treatment (3) with the ultra-brief relaxation (control) group.\n\nThe main questions the study aims to answer are:\n\n* Will the brief and ultra-brief treatment formats works better than the relaxation-based control group?\n* Will results obtained between the brief group therapy group and the ultra-brief group therapy group be similar?\n* Will the individual ultra brief therapy be more effective than the two group therapies because of common factors, such as the therapeutic alliance?\n* Will group therapies be more beneficial for cost and in terms of capability to reduce emocional symptoms than individual therapy? Participants will be randomly assigned to each of the groups and will receive the corresponding treatment, with different number of sessions. They will answer a series of questionnaires at the beginning and at the end of the intervention, as well as 3 months and 6 months after the end of the treatment.",[28,29,30,31,32,33,34,35],"Depression - Major Depressive Disorder","Generalized Anxiety Disorder","Generalized Anxiety","Anxiety","Somatoform Disorders","Somatic Symptom Disorder (DSM-5)","Somatization","Emotional Disorders",[37,38,39,40,41],"ultra-brief therapy","brief therapy","transdiagnostic therapy","cognitive-behavioral therapy","randomized controled trial","NOT_YET_RECRUITING","2025-12-15",{"date":45,"type":46},"2025-12-22","ACTUAL",{"date":48,"type":22},"2026-02",{"date":50,"type":22},"2028-09",{"name":52,"class":53},"Universidad de Córdoba","OTHER",2,{"id":56,"slug":57,"hasResults":11,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":63,"enrollmentInfo":64,"targetDuration":4,"studyType":23,"phases":66,"briefSummary":67,"conditions":68,"keywords":4,"overallStatus":74,"whyStopped":4,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":84},"100479639","internet-based-treatment-for-patients-suffering-from-severe-functional-somatic-disorders-100479639","NCT05525598","Internet-based Treatment for Patients Suffering From Severe Functional Somatic Disorders","Internet-based Treatment for Patients Suffering From Severe Functional Somatic Disorders: A Randomized Controlled Trial.","OneSTEP","Inclusion Criteria:\n\n* Patients must fulfil the criteria for moderate-severe FSD operationalized as being diagnosed with either single\u002Foligo-organ BDS, with 2 organ systems that are each affected by 3 or more symptoms, or multi-organ BDS, with 3 or 4 organ systems that are each affected by 3 or more symptoms.\n* Patients must have symptom duration \\> 6 months.\n* If older than 25, patients must have been active in the labor market or educational system for at least 12 months during the last 2 years.\n* Patient must have access to a computer or tablet with internet connection.\n* Patient must be able to understand, read, and write Danish fluently.\n\nExclusion Criteria:\n\n* Patients are excluded from participation if they present with severe comorbid somatic or psychiatric disease that is insufficiently treated at the time of assessment and is deemed to constitute a potential barrier for engaging in the treatment.\n* Patients are excluded if they lack motivation to engage in internet-delivered treatment.\n* Patients are excluded if they have poor self-reported IT skills.\n* Patients are excluded if they lack informed consent.\n* Patients are excluded if they have ongoing treatments with opioids and benzodiazepines.\n* Patient's use of psychoactive medications should be stable.","60 Years",{"count":65,"type":22},166,[25],"The aim of this multi-center, two-armed, randomized controlled trial is to assess the effect of a novel internet-based therapist-assisted treatment program \"One step at a time\" designed for the treatment of patients with moderate to severe functional somatic disorder (FSD).\n\nThe trial will enroll 166 patients with FSD who will be randomized (1:1) to either the experimental condition (14 weeks' treatment with \"One step at a time\") or the active control condition (\"GetStarted\"), which is a non-guided internet-based treatment program for patients with FSD. The trial will include patients aged 18-60 years with an established single\u002Foligo-organ or multi-organ FSD diagnosis, with a duration of minimum 6 months. The primary outcome measures will be based on self-reported physical health (SF-36 PPH) and treatment satisfaction (CGI-I). The trial will be considered effective if a higher proportion of patients in the experimental condition report a clinically significant outcome compared with patients in the active control condition at the 3-month follow-up after treatment.",[69,70,71,72,73,34],"Bodily Distress Disorder Moderate","Bodily Distress Disorder Severe","Fibromyalgia","Chronic Fatigue Syndrome","Irritable Bowel Syndrome","RECRUITING","2025-06-23",{"date":77,"type":46},"2025-06-27",{"date":79,"type":46},"2022-08-24",{"date":81,"type":22},"2026-10-31",{"name":83,"class":53},"University of Aarhus",1,{"id":86,"slug":87,"hasResults":11,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":93,"sex":94,"minAge":18,"maxAge":95,"enrollmentInfo":96,"targetDuration":4,"studyType":98,"phases":4,"briefSummary":99,"conditions":100,"keywords":104,"overallStatus":74,"whyStopped":4,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":54},"100476574","perinatal-mental-health-study-pmhs-india-100476574","NCT05485701","Perinatal Mental Health Study (PMHS) India","Perinatal Mental Health Study (PMHS): a Cohort and Validation Study in Two Low-income Settings in India","PMHS","Inclusion Criteria:\n\nFor Phase 1 (qualitative study) and Phase 2 (validation study):\n\nPregnant women:\n\n* Aged 18 to 45 years\n* Currently pregnant (any trimester)\n* Willing and able to give informed consent\n\nPost-partum women:\n\n* Aged 18 to 45 years\n* Currently post-partum (between 1-12 months postpartum)\n* Willing and able to give informed consent\n\nNon-perinatal women:\n\n* Aged 18 to 45 years\n* Not currently pregnant and not given birth in the past 12 months\n* Willing and able to give informed consent\n\nFor Phase 3 (prospective cohort study):\n\nPerinatal women:\n\n* Aged 18 to 45 years\n* In early pregnancy (estimated gestational age \\\u003C20 weeks) at recruitment\n* Not planning to relocate for the duration of the study period\n* Willing and able to give informed consent\n* Expressed a willingness to continue to participate for the four planned visits\n\nNon-perinatal women:\n\n* Aged 18 to 45 years\n* Not currently pregnant and not given birth in the last 12 months\n* Not planning to relocate for the duration of the study period\n* Willing and able to give informed consent\n* Expressed a willingness to continue to participate for the four planned visits\n\nExclusion Criteria:\n\nThe participant may not enter the study if:\n\n* They have an acutely severe psychiatric illness which impairs their ability to take part in the study\n* They are not willing or able to provide informed consent\n\nOther than for current severe psychiatric illness which affects ability to participate in the study, we will not exclude any participant on the basis of current or prior physical, psychological or psychiatric co-morbidities so long as she is willing to participate, her ability to take part is not compromised and her ability to give informed consent is not impaired by these conditions.",true,"FEMALE","45 Years",{"count":97,"type":22},2332,"OBSERVATIONAL","The purpose of this observational study is to improve understanding of mental disorders among perinatal women in India.",[101,31,102,34,103],"Depression","Suicidal Ideation","PTSD",[105,106,107,108,109,110,111,112,113,114],"Perinatal","Post-partum","Antenatal","Low- and middle-income country","India","Common mental disorders","Screening","Validation","Prevalence","Risk factor","2023-11-30",{"date":117,"type":46},"2023-12-07",{"date":119,"type":46},"2022-09-01",{"date":121,"type":22},"2026-08-31",{"name":123,"class":53},"University of Oxford"]